Syquant Capital SAS’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Syquant Capital SAS’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-190,654	Closed	-$3M	–	12
2023 Q4	$3M	Buy	+190,654	New	+$1.84M	13.56%	3

Syquant Capital SAS's ICVX Position: Q1 2024 in Review

Syquant Capital SAS sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 190,654 shares — an estimated $3M sold.

Syquant Capital SAS first reported a position in ICVX in Q4 2023 and held it in 1 quarter. The position peaked at $3M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Syquant Capital SAS reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Syquant Capital SAS sold 190,654 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $3M.
Syquant Capital SAS first reported a position in Icosavax, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Syquant Capital SAS's Icosavax, Inc. Common Stock position peaked at $3M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Syquant Capital SAS's 13F filing for Q1 2024, filed 9 Apr 2024.